MedTrace Logo

Lung Protection in ARDS Using Neurally Adjusted Ventilatory Assist

NCT03868982 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-10-26

No results posted yet for this study

Summary

The aim of this study is to investigate the use neurally adjusted ventilatory assist (NAVA) as lung protective strategy in patients with acute respiratory distress syndrome (ARDS).

Conditions

  • ARDS, Human
  • Mechanical Ventilation Pressure High

Interventions

DEVICE

Neurally adjusted ventilatory assist

NAVA uses the diaphragm activity to deliver mechanical ventilation

Sponsors & Collaborators

  • Fu Jen Catholic University

    lead OTHER

Principal Investigators

  • Wen-Lun Liu, MD · Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2023-06-30
Completion
2023-12-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03868982 on ClinicalTrials.gov